Background {#Sec1}
==========

The aim of volume expansion, during acute circulatory failure, is to increase cardiac index (CI) and oxygen delivery (DO~2~) and to improve tissue oxygenation. Unrecognizable and untreated global tissue hypoxia is thought to contribute to the development of multiple organ failure or death. The usual indicators of global tissue hypoxia, such as blood lactate and venous oxygen saturation, are misleading. Increased lactate levels in sepsis are traditionally viewed as the result of activation of anaerobic glycolysis pathway due to inadequate oxygen delivery. According to such paradigms, hyperlactatemia signals tissue hypoxia and hypoperfusion \[[@CR1], [@CR2]\]. Nevertheless, in septic states, lactate concentration may increase through other mechanisms unrelated to tissue oxygen debt \[[@CR3], [@CR4]\]. Therefore, hyperlactatemia does not necessarily reflect anaerobic metabolism secondary to cellular hypoxia.

Measurement of mixed or central venous oxygen saturation (ScvO~2~) has been advocated in order to detect global tissue hypoxia \[[@CR5]\]. ScvO~2~ reflects the balance between oxygen consumption and supply. A low ScvO~2~ represents a high oxygen extraction (OE) in order to maintain oxygen consumption (VO~2~) in spite of low DO~2~. However, a low ScvO~2~ does not necessarily indicate the presence of VO~2~/DO~2~ dependency. It is when ScvO~2~ cannot decrease proportionally to the decline of DO~2~ to maintain VO~2~, that cell moves from aerobic to anaerobic metabolism, leading to tissue hypoxia \[[@CR6]\]. On the other hand, in septic shock, due to impairment of OE, normal/high ScvO~2~ values can also be observed in the presence of oxygen debt \[[@CR5], [@CR6]\]. Therefore, other markers are needed to indicate the presence of anaerobic metabolism in critically ill patients.

Considering the ratio of the venous-to-arterial CO~2~ tension difference (∆PCO~2~) over the arterial-to-venous oxygen content difference (∆ContO~2~) as a surrogate of the respiratory quotient (RQ), it has been suggested that this ratio can be used as a marker of global anaerobic metabolism in critically ill patients \[[@CR7]\]. Recently, Monnet et al. \[[@CR8]\] found that this ratio, calculated from central venous blood, predicted an increase in VO~2~ after a fluid-induced increase in DO~2~ and, thus, can be able to detect the presence of global tissue hypoxia. However, PCO~2~ is not equivalent to CO~2~ content, and the PCO~2~/CO~2~ content relationship is curvilinear rather than linear and is influenced by many factors such as pH and oxygen saturation (Haldane effect). Although VCO~2~/VO~2~ might be better reflected by the venous-to-arterial CO~2~ content over ∆ContO~2~ (∆ContCO~2~/∆ContO~2~) ratio, there is no report in the literature whether this latter ratio can predict more accurately a situation of anaerobic metabolism than ∆PCO~2~/∆ContO~2~ ratio. Therefore, the aim of our study was to evaluate the ability of ∆ContCO~2~/∆ContO~2~, ∆PCO~2~/∆ContO~2~, ScvO~2~, and blood lactate to predict the presence of the activation of global anaerobic metabolism through VO~2~/DO~2~ dependence in septic shock patients. The presence of VO~2~/DO~2~ dependency phenomenon was characterized by the increase in VO~2~ after an acute increase in DO~2~ induced by volume expansion (VE).

Methods {#Sec2}
=======

This prospective single-center observational study was conducted in a general adult intensive care unit (ICU) after approval by our local institutional ethics committee (Lens Hospital, France). Informed consent was obtained from each subject's next of kin.

Patients {#Sec3}
--------

We studied mechanically ventilated patients for whom the attending physician decided to perform a VE due to the presence of at least one clinical sign of inadequate tissue perfusion due to septic shock \[[@CR2]\]: (a) systolic arterial pressure \<90 mmHg, mean arterial pressure \<65 mmHg, or the need for vasopressor infusion; (b) skin mottling; (c) lactate level \>2 mmo/L; or (d) urinary output \<0.5 mL/kg/h for ≥2 h. Septic shock was defined according to international criteria \[[@CR9]\]. Patients had also to be monitored by PiCCO device (PiCCO, Pulsion Medical System, Munich, Germany) as part of routine management of persistent signs of tissue hypoperfusion in our ICU. Exclusion criteria were: liver failure as defined by Sequential Organ Failure Assessment score, pregnancy, age \<18 years old, moribund, and risk of fluid loading-induced pulmonary edema.

Measurements {#Sec4}
------------

CI was obtained with the PiCCO monitor by triplicate central venous injections, in either the internal jugular or subclavian vein, of 20 mL of iced 0.9 % saline solution and recorded as the average of the three measurements.

Arterial lactate levels, arterial, and central venous blood gas were measured using the GEM Premier 4000 (Instrumentation Laboratory Co, Paris, France). The central venous blood was obtained from a central venous catheter with the tip confirmed to be in the superior vena cava at the entrance, or in the right atrium by radiograph. The ∆PCO~2~ was calculated as the difference between the central venous carbon dioxide tension and the arterial carbon dioxide tension. The arterial (CaO~2~) and central venous (CcvO~2~) oxygen contents were calculated using the standard formulas (Additional file [1](#MOESM1){ref-type="media"}: Supplementary material). The ∆ContO~2~ (mL) was calculated as CaO~2~--CcvO~2~. The DO~2~ was calculated by using the formula: DO~2~ (mL/min/m^2^) = CaO~2~ × CI × 10. The VO~2~ was calculated using the following formula: VO~2~ (mL/m^2^) = CI × ∆ContO~2~ × 10. Oxygen extraction was defined as: OE = VO~2~/DO~2~.

We also determined the central venous-to-arterial difference in blood CO~2~ content \[∆ContCO~2~\] according to Douglas et al. \[[@CR10]\] (Additional file [1](#MOESM1){ref-type="media"}: Supplementary material).

Study protocol {#Sec5}
--------------

At baseline, a first set of measurements was performed, including hemodynamic and tissue oxygenation variables (Additional file [1](#MOESM1){ref-type="media"}: Supplementary material), arterial lactate level, ∆PCO~2~, ∆ContCO~2~/∆ContO~2~ ratio, and ∆PCO~2~/∆ContO~2~ ratio. A 500 mL of colloid solution (4 % human serum albumin, Vialebex^®^; LFB) was infused to the patient over 15 min via a specific venous line. Immediately after VE, a second set of measurement was recorded, including the same hemodynamic and tissue oxygenation variables. Ventilation parameters and doses of norepinephrine, dobutamine, and sedation drugs were kept constant during the VE.

Statistical analysis {#Sec6}
--------------------

According to changes in CI after the 500-mL VE, patients were classified as fluid-responders (≥15 % increase in CI) or fluid-non-responders. Also, in the fluid-responders' group, patients were separated into two subgroups according to their increase in VO~2~ (\< or ≥15 %) induced by VE \[[@CR8]\]. All data are expressed as mean ± SD when they are normally distributed, or as median \[25--75 %, interquartile range, (IQR)\] when they are non-normally distributed. The normality of data distribution was assessed using the Kolmogorov--Smirnov test. Comparisons of values between different groups of patients were made by two-tailed Student's t test, or Mann--Whitney U test, as appropriate. Pairwise comparisons between different study times were assessed using paired Student's t test or Wilcoxon's test, as appropriate. Linear correlations were tested by using the Pearson or the Spearman test, as appropriate. To adjust for the regression to the mean phenomenon, the absolute change in variables over time was also analyzed by performing an analysis of covariance (ANCOVA) with the absolute change in variable as dependent variable, the group of patients as a factor, and the baseline value as a covariate.

Receiver operating characteristics (ROC) curves were constructed to evaluate the ability of tissue oxygenation variables at baseline to predict an increase of VO~2~ ≥ 15 % after VE in fluid-responders' group. The areas under the ROC curves (AUCs) were compared using the nonparametric technique described by DeLong et al. \[[@CR11]\]. The best cutoff of a ROC curve was chosen with the highest Youden index \[[@CR12]\]. Usually, variables are considered of good clinical tool (having good discriminative properties tests) when the inferior limits of the 95 % confidence interval (CI) of their AUC are more than 0.75 \[[@CR12]\]. For this purpose, considering a proportion of VO~2~ responders of 21 % \[[@CR8]\], 51 fluid-responder's patients are required for a power of 90 % and an alpha risk of 0.05. Assuming a proportion of responders close to 50 %, about 102 patients would be necessary. Statistical analysis was performed using STATA 14.0 (StataCorp LP, College Station, Texas, USA) and SPSS for Windows release 17.0 (Chicago, Illinois, USA). p \< 0.05 was considered statistically significant. All reported P values are two-sided.

Results {#Sec7}
=======

Patients {#Sec8}
--------

Ninety-eight septic shock patients were prospectively included in this study. The main characteristics of the cohort are summarized in Table [1](#Tab1){ref-type="table"}. The median time between the start of care and enrollment was 1.7 \[1.0--2.0\] h. The major source of infection was pneumonia (55 %) with ICU mortality rate of 42.8 %.Table 1Baseline characteristics of the patients (n = 98)Age (mean ± SD, years)63 ± 11Body masse index (mean ± SD, kg/m^2^)26.6 ± 5.4Gender (female/male) (n)41/57Simplified acute physiologic score (mean ± SD)64 ± 18Sequential organ failure assessment score (median \[IQR\])10 \[6--12\]ICU mortality \[n (%)\]42 (42.8)Time between diagnosis and inclusion (median \[IQR\], h)1.7 \[1.0--2.0\]Infection source \[n (%)\]Pneumonia54 (55)Peritonitis34 (35)Meningitis5 (5)Urinary tract infection5 (5)Patients receiving norepinephrine \[n (%)\]98 (100)Norepinephrine dose (median \[IQR\], µg/kg/min)0.24 \[0.11--0.55\]Patients receiving dobutamine \[n (%)\]21 (21.4)Dobutamine dose (median \[IQR\], µg/kg/min)5 \[5--10\]Mechanical ventilation \[n (%)\]98 (100)*IQR* interquartile range, *ICU* intensive care unit

The whole population {#Sec9}
--------------------

At baseline, there was a significant but weak correlation between lactate and ∆PCO~2~/∆ContO~2~ (r = 0.33, p = 0.001) and between lactate and ∆ContCO~2~/∆ContO~2~ (r = 0.32, p = 0.001). Furthermore, fluid-induced changes in ∆PCO~2~/∆ContO~2~, ∆ContCO~2~/∆ContO~2~, and lactate were weakly correlated (r = 0.25, p = 0.01 and r = 0.21, p = 0.04; respectively). We found a good correlation between ∆ContCO~2~/∆ContO~2~ and ∆PCO~2~/∆ContO~2~ ratios (r = 0.63, p \< 0.001). Fluid-induced changes in ∆PCO~2~/∆ContO~2~ and ∆ContCO~2~/∆ContO~2~ ratios were also well related (r = 0.63, p \< 0.001).

Effects of volume expansion on hemodynamic variables {#Sec10}
----------------------------------------------------

VE increased CI by more than 15 % in 51 patients who were "fluid-responders" (52 %; Additional file [2](#MOESM2){ref-type="media"}: Table S1). In these patients, VE significantly increased CI by 30 ± 13 %, DO~2~ by 31 ± 12 %, and VO~2~ by 25 ± 26 % (Additional file [2](#MOESM2){ref-type="media"}: Table S1). Volume expansion induced less than 15 % increase in CI in 47 patients (48 %). In these patients, we observed no significant changes in DO~2~ and VO~2~.

Differences between VO~2~-responders and VO~2~-non-responders in fluid-responders' group {#Sec11}
----------------------------------------------------------------------------------------

Of the 51 fluid-responders, VE increased VO~2~ ≥ 15 % (45 ± 16 %) in 29 who were "VO~2~-responders." In the remaining 22 fluid-responders, VE did not significantly change VO~2~ "VO~2~-non-responders" (Table [2](#Tab2){ref-type="table"}; Fig. [1](#Fig1){ref-type="fig"}).Table 2Hemodynamic and tissue oxygenation parameters before and after 500 mL of volume expansion according to the response of VO~2~ in fluid-responder patientsVO~2~ change ≥15 % (n = 29)VO~2~ change \<15 % (n = 22)Before volume expansionAfter volume expansionBefore volume expansionAfter volume expansionHeart rate (beats/min)108 ± 34102 ± 26\*110 ± 27109 ± 26Mean arterial pressure (mmHg)66 ± 1679 ± 13\*74 ± 1385 ± 10\*Cardiac index (L/min/m^2^)2.59 \[1.42--3.03\]3.02 \[2.09--3.71\]\*3.25 \[2.49--3.65\]^\#^3.81 \[3.48--4.23\]^\#,^\*Stroke index (mL/m^2^)19.4 \[13.1--35.9\]27.0 \[22.5--43.8\]\*30.8 \[21.5--34.1\]^\#^41.0 \[31.6--41.4\]\*Minute ventilation (L/min)10.4 ± 2.0--8.5 ± 1.5^\#^--Arterial pH7.35 \[7.32--7.38\]7.36 \[7.35--7.37\]7.23 \[7.21--7.30\]^\#^7.22 \[7.22--7.31\]^\#^Base excess (mmol/L)--7.21 ± 4.74--7.11 ± 4.21--8.15 ± 4.20--8.25 ± 3.89SaO~2~ (%)99 \[90--100\]98 \[94--100\]94 \[91--96\]^\#^95 \[92--98\]^\#,^\*Hemoglobin (g/dL)10.1 ± 1.39.5 ± 1.1\*10.7 ± 1.010.1 ± 0.9^\#,^\*CaO~2~ (mL)12.8 ± 2.012.8 ± 1.713.2 ± 1.413.2 ± 1.2PaCO~2~31 ± 531 ± 643 ± 8^\#^42 ± 7^\#^CaCO~2~ (mL)37.1 \[30.0--49.2\]37.2 \[28.8--46.4\]\*40.5 \[35.6--46.9\]37.2 \[34.9--42.8\]\*Venous pH7.31 \[7.24--7.34\]7.33 \[7.27--7.33\]7.22 \[7.18--7.24\]^\#^7.21 \[7.20--7.27\]^\#,^\*ScvO~2~ (%)63 ± 1163 ± 1058 ± 1469 ± 10^\#^,\*CcvO~2~ (mL)8.4 ± 2.08.1 ± 1.6\*8.2 ± 2.29.6 ± 1.8^\#,^\*PcvCO~2~ (mmHg)40 ± 738 ± 7\*49 ± 7^\#^47 ± 6^\#,^\*CcvCO~2~ (mL)43.4 \[35.1--53.3\]41.4 \[31.8--49.6\]\*43.6 \[40.2--47.3\]39.9 \[37.9--43.3\]\*DO~2~ (mL/min/m^2^)297 ± 86381 ± 84\*409 ± 80^\#^529 ± 84^\#,^\*VO~2~ (mL/min/m^2^)95 ± 27134 ± 30\*148 ± 43^\#^145 ± 37OE0.34 ± 0.110.37 ± 0.10\*0.37 ± 0.150.28 ± 0.09^\#,^\*∆PCO~2~ (mmHg)7.0 \[6.0--14.0\]6.0 \[5.0--12.0\]\*4.0 \[3.7--9.0\]^\#^3.0 \[3.0--6.0\]^\#,^\*∆ContO~2~ (mL)4.3 ± 1.64.7 ± 1.4\*5.0 ± 2.13.7 ± 1.1^\#,^\*∆ContCO~2~ (mL)5.2 \[3.9--6.3\]3.0 \[2.8--4.2\]\*1.8 \[0.3--4.7\]^\#^1.5 \[0.5--3.3\]^\#,^\*∆PCO~2~/∆ContO~2~ (mmHg/mL)2.20 \[1.70--2.33\]1.66 \[1.10--1.96\]\*1.05 \[1.02--1.14\]^\#^1.13 \[0.83--1.35\]^\#^∆ContCO~2~/∆ContO~2~1.22 \[1.05--1.26\]0.65 \[0.65--0.70\]\*0.53 \[0.09--0.64\]^\#^0.46 \[0.14--0.70\]^\#^Lactate (mmol/L)5.8 \[3.2--7.6\]5.0 \[2.8--6.9\]\*2.9 \[2.1--4.9\]^\#^2.7 \[1.4--4.4\]^\#,^\*Data are expressed as mean ± SD or as median \[interquartile range, 25--75\]*SaO* ~*2*~ arterial oxygen saturation, *CaO* ~*2*~ arterial oxygen content, *PaCO* ~*2*~ arterial carbon dioxide tension, *ScvO* ~*2*~ central venous oxygen saturation, *CcvO* ~*2*~ central venous oxygen content, *PcvCO* ~*2*~ central venous carbon dioxide tension, *DO* ~*2*~ oxygen delivery, *VO* ~*2*~ oxygen consumption, *∆PCO* ~*2*~ venous--arterial carbon dioxide tension difference, *CaCO* ~*2*~ arterial carbon dioxide content, *CcvCO* ~*2*~ central venous carbon dioxide content, *∆ContO* ~*2*~ arterial-to-central venous oxygen content difference, *∆ContCO* ~*2*~ central venous-to-arterial carbon dioxide content difference, *OE* oxygen extraction\* p \< 0.05 after vs. before volume expansion. ^\#^p \< 0.05 patients with a VO~2~ \< 15 % versus patients with a VO~2~ ≥ 15 %Fig. 1Flow chart showing the original 98 patients separated according to their response to volume expansion in terms of cardiac index, fluid responsiveness, and oxygen consumption (VO~2~)

At baseline, compared with the VO~2~-non-responders, lactate levels and ∆PCO~2~/∆ContO~2~ and ∆ContCO~2~/∆ContO~2~ ratios were significantly higher in VO~2~-responders, whereas ScvO~2~ value was not significantly different between these two subgroups (Table [2](#Tab2){ref-type="table"}). In these patients, ∆PCO~2~/∆ContO~2~ and ∆ContCO~2~/∆ContO~2~ ratios decreased significantly by 30 ± 13 and 45 ± 24 % (respectively) with VE, whereas they did not change in VO~2~-non-responders (Table [2](#Tab2){ref-type="table"}). ScvO~2~ significantly increased (22 ± 16 %) with VE only in VO~2~-non-responders (Table [2](#Tab2){ref-type="table"}).

Lactate levels decreased significantly with VE in both VO~2~-responders and VO~2~-non-responders. The magnitude of decrease in lactate levels was not different between these two subgroups (13 ± 7 % for VO~2~-responders vs. 13 ± 10 % for VO~2~-non-responders, p = 0.98, Table [2](#Tab2){ref-type="table"}).

Among fluid-responder patients, VE-induced changes in ∆PCO~2~/∆ContO~2~, ∆ContCO~2~/∆ContO~2~, and ScvO~2~, but not in lactate, were significantly higher, after adjustment to their baseline values, in VO~2~-responders than in VO~2~-non-responders (ANCOVA, p \< 0.001, p = 0.006, p \< 0.001, and p = 0.18; respectively).

VE-induced change in VO~2~ was not significantly correlated with the changes in lactate (r = −0.17, p = 0.22). However, changes in both ∆PCO~2~/∆ContO~2~ and ∆ContCO~2~/∆ContO~2~ ratios induced by VE were well correlated with changes in VO~2~ (r = −0.52, p \< 0.001, and r = −0.59, p \< 0.001; respectively).

Ability of tissue oxygenation variables to predict the response of VO~2~ to VE in fluid-responders {#Sec12}
--------------------------------------------------------------------------------------------------

The ability of ∆PCO~2~/∆ContO~2~ and ∆ContCO~2~/∆ContO~2~ at baseline to predict an increase of VO~2~ ≥ 15 % induced by VE was excellent in fluid-responder patients with AUCs of 0.962 (95 % CI 0.900--1.000) and 0.965 (95 % CI 0.918--1.000), respectively (Fig. [2](#Fig2){ref-type="fig"}). The AUC for baseline value of lactate was 0.745 \[(95 % CI 0.608--0.883), p = 0.003 vs. 0.5\]. However, ScvO~2~ at baseline did not predict the VO~2~ increase of ≥15 % \[AUC = 0.624, (95 % CI 0.449--0.798), p = 0.14 vs. 0.5\].Fig. 2Receiver operating characteristic (ROC) curves showing the ability of baseline ∆ContCO~2~/∆ContO~2~, ∆PCO~2~/∆ContO~2~, lactate, and ScvO~2~ to predict an increase in oxygen consumption of ≥15 % induced by volume expansion

AUCs for baseline ∆PCO~2~/∆ContO~2~ and ∆ContCO~2~/∆ContO~2~ ratios were both significantly larger than the AUCs for baseline lactate (p = 0.003 and p = 0.002, respectively) and baseline ScvO~2~ (p \< 0.001 for both ratios, Fig. [2](#Fig2){ref-type="fig"}). However, there were no significant differences between AUC for ∆PCO~2~/∆ContO~2~ and AUC for ∆ContCO~2~/∆ContO~2~ (p = 0.80), neither between AUC for baseline lactate and AUC for baseline ScvO~2~ (p = 0.24).

The best cutoff values at baseline, when predicting VO~2~ responsiveness, were ≥1.68 mmHg/mL for ∆PCO~2~/∆ContO~2~ ratio \[sensitivity = 90 % (95 % CI 71--97 %); specificity = 100 % (95 %CI 81--100 %)\], ≥1.02 for ∆ContCO~2~/∆ContO~2~ ratio \[sensitivity = 86 % (95 % CI 67--95 %); specificity = 100 % (95 % CI 81--100 %)\], and ≥4.6 mmol/L for lactate \[sensitivity = 69 % (95 % CI 49--84 %); specificity = 77 % (95 % CI 54--91 %)\] (Table [3](#Tab3){ref-type="table"}). Even though the AUC for baseline ScvO~2~ was not significantly different from 0.5, a ScvO~2~ value ≥80 % had a specificity of 100 % (95 % CI 81--100 %) but a sensitivity of 21 % (95 % CI 9--40 %) to predict the VO~2~ increase ≥15 %. Thus, in fluid-responders, a ScvO~2~ value ≥80 % was always associated with an increase in VO~2~ ≥ 15 % induced by VE. Compared with patients with a baseline ScvO~2~ \< 80 %, these patients had higher baseline lactate levels \[4.3 (2.3--6.3) mmol/L vs. 7.6 (5.6--8.1) mmol/L, p = 0.011; respectively\], higher baseline ∆PCO~2~/∆ContO~2~ ratio \[1.46 (1.05--2.17) mmHg/mL vs. 2.20 (2.20--2.38) mmHg/mL, p = 0.011; respectively\], and higher baseline ∆ContCO~2~/∆ContO~2~ ratio \[0.94 (0.53--1.05) vs. 1.52 (1.42--1.62), p \< 0.001; respectively\].Table 3Diagnostic ability of baseline values of central venous-to-arterial CO~2~ tension and content differences to arterial-to-venous oxygen content difference ratios, and baseline lactate values to predict fluid-induced increase in oxygen consumption ≥15 % in fluid-responder patients (n = 51)Best cutoff valueSe (%) (95 % CI)Sp (%) (95 % CI)PPV (%) (95 % CI)NPV (%) (95 % CI)LR^+^ (95 % CI)LR^−^ (95 % CI)∆PCO~2~/∆ContO~2~ (mmHg/mL)1.6890 (71--97)100 (81--100)100 (84--100)88 (68--97)Infinity0.10 (0.03--0.30)∆ContCO~2~/∆ContO~2~1.0286 (67--95)100 (81--100)100 (83--100)85 (64--95)Infinity0.14 (0.05--0.34)Lactate (mmol/L)4.669 (49--84)77 (54--91)80 (59--92)65 (44--82)3.03 (1.35--6.81)0.40 (0.23--0.71)*Se* sensitivity, *Sp* specificity, *PPV* positive predictive value, *NPV* negative predictive value, *LR* ^*+*^ positive likelihood ratio, *LR* ^*−*^ negative likelihood ratio, *CI* confidence interval

Comparisons between patients with ScvO~2~ \> 70 % and patients with ScvO~2~ ≤ 70 % at baseline in the whole population {#Sec13}
----------------------------------------------------------------------------------------------------------------------

Only 28 patients had a ScvO~2~ of more than 70 % at baseline (Additional file [3](#MOESM3){ref-type="media"}: Table S2). They had significantly lower baseline VO~2~ and higher baseline DO~2~ compared with patients with low baseline ScvO~2~. The mean baseline value of VO~2~ significantly increased with volume expansion only in patients with ScvO~2~ \> 70 % (Additional file [3](#MOESM3){ref-type="media"}: Table S2).

Discussion {#Sec14}
==========

The main findings of our study were that in fluid-responder septic shock patients (1) the ability of ∆ContCO~2~/∆ContO~2~ and ∆PCO~2~/∆ContO~2~ ratios to predict the presence of global anaerobic metabolism was excellent and higher than lactate; (2) ∆ContCO~2~/∆ContO~2~ ratio was not a better marker of global anaerobic metabolism than ∆PCO~2~/∆ContO~2~ ratio; (3) ScvO~2~ failed to detect the presence of global tissue hypoxia, except for values ≥80 %.

When DO~2~ is acutely reduced, VO~2~ remains stable (oxygen supply independency) because the tissues adapt their OE proportionally. When DO~2~ falls below a critical low value, a proportionate increase in OE cannot be maintained and the VO~2~ starts to fall (oxygen supply dependency) and tissue hypoxia occurs as reflected by an abrupt increase in blood lactate concentration \[[@CR13]--[@CR15]\]. Thus, VO~2~/DO~2~ dependence has been considered to be a hallmark of tissue hypoxia and the activation of anaerobic metabolism \[[@CR14]--[@CR16]\], although it has been challenged because of the methodological limitations (mathematical coupling) in the VO~2~/DO~2~ relationship assessment \[[@CR17], [@CR18]\].

We defined an increase in VO~2~ ≥ 15 % as a clinically significant augmentation by similarity to the definition of the increase in cardiac index, since VO~2~ is proportional to this variable. This cutoff value was chosen by the fact that the least significant change in CI measured by transpulmonary thermodilution is 11.0 % when 20 mL is used to perform iced saline injections in triplicate (unpublished data). On the other hand, this definition of "VO~2~ response" allows us comparing our findings with those of a previous study \[[@CR8]\]. We confirm the results of Monnet et al. \[[@CR8]\] that calculating VO~2~ from the central instead of the mixed venous blood also allows to detect the presence of anaerobic metabolism through VO~2~/DO~2~ dependence. Indeed, in our study, the baseline lactate concentration was elevated in patients with VO~2~/DO~2~ dependency phenomenon and higher than in patients with VO~2~/DO~2~ independency (Table [2](#Tab2){ref-type="table"}). Moreover, it is hard to believe that mathematical coupling of measurement errors was responsible for the VO~2~/DO~2~ dependency in our study. Indeed, we observed that VO~2~/DO~2~ dependency occurred in one subgroup of patients but not in others, despite similar changes in DO~2~ (Table [2](#Tab2){ref-type="table"}). Such a methodological problem can hardly account for the existence of VO~2~/DO~2~ dependency only in one subgroup. If that were an issue, one would expect it to influence results uniformly. Finally, the increase in VO~2~ could have resulted from an additional non-mitochondrial non-oxidative oxygen uptake when dysoxia has resolved \[[@CR19]\]. However, this mechanism is less likely to have occurred in our study because the observed mean slope of the VO~2~/DO~2~ relationship in the subgroup of VO~2~-responders was 47.8 ± 10 %, suggesting VO~2~/DO~2~ dependency and activation of anaerobic metabolism (Table [2](#Tab2){ref-type="table"}) \[[@CR20]\].

In experimental conditions of tissue hypoxia, a smaller reduction in VCO~2~ than VO~2~ has been observed, suggesting a non-aerobic production of CO~2~ \[[@CR21]--[@CR23]\]. Therefore, the occurrence of a high RQ may be considered as a sign of anaerobic metabolism. Recently, Monnet et al. \[[@CR8]\] have used the ∆PCO~2~/∆ContO~2~ ratio as a surrogate of RQ and found that a ∆PCO~2~/∆ContO~2~ ratio at baseline ≥ 1.8 mmHg/mL predicted accurately VO~2~/DO~2~ dependence among patients whose DO~2~ increased after fluid administration. Our results agree with those findings, and interestingly, the observed cutoff value of this ratio, in our septic shock patients, was almost similar to what was found in the Monnet et al. report \[[@CR8]\].

The use of ∆PCO~2~/∆ContO~2~ ratio as a surrogate of VCO~2~/VO~2~ assumes that the PCO~2~/CO~2~ content relationship is quasi-linear, which may be true over the physiologic range of PCO~2~ \[[@CR24]\]. However, this relationship can be affected by the degree of metabolic acidosis, hematocrit, and oxygen saturation (Haldane effect), and it becomes nonlinear if these factors change \[[@CR25]\]. In this regard, it has been shown that venous-to-arterial PCO~2~ differences and venous-to-arterial CO~2~ content differences might change in opposite direction in splanchnic region under conditions of very low venous oxygen saturation \[[@CR26]\]. Recently, Ospina-Tascon et al. found a significant association with mortality, in septic shock patients, for the mixed ∆ContCO~2~/mixed ∆ContO~2~ ratio but not for the mixed ∆PCO~2~/mixed ∆ContO~2~ ratio \[[@CR27]\]. Thus, ∆ContCO~2~/∆ContO~2~ ratio could be a more reliable marker of tissue hypoxia than ∆PCO~2~/∆ContO~2~. However, we found that ∆ContCO~2~/∆ContO~2~ was not better predictor of tissue hypoxia than the ∆PCO~2~/∆ContO~2~ in septic shock patients (Fig. [2](#Fig2){ref-type="fig"}). It does not seem that Haldane effect has played an important role in our study. Furthermore, the degree of metabolic acidosis, as reflected by base excess, was not severe enough to significantly affect the PCO~2~/CO~2~ content relationship in our septic shock patients. Even though the ∆ContCO~2~/∆ContO~2~ ratio more physiologically mirrors RQ compared with ∆PCO~2~/∆ContO~2~, we found that both ratios can be used accurately to predict fluid responsiveness at tissue level. However, the computation of ∆PCO~2~/∆ContO~2~ ratio is less cumbersome and less subject to the risk of errors, and therefore, it is much easier to be used at the bedside.

Lactate value was not good to detect the presence of anaerobic metabolism in our septic shock patients. Our results are in discrepancy with previous findings \[[@CR7], [@CR8], [@CR28]\]. However, hyperlactatemia does not necessarily reflect anaerobic metabolism secondary to tissue hypoxia, especially in septic states \[[@CR3], [@CR4], [@CR29]\]. Other non-hypoxic mechanisms such as accelerated aerobic glycolysis induced by sepsis-associated inflammation \[[@CR30]\], inhibition of pyruvate dehydrogenase \[[@CR31]\], and impaired lactate clearance \[[@CR32]\] may contribute to hyperlactatemia found in septic patients. In endotoxic states, lactate levels failed to discriminate between hypoxia and aerobiosis \[[@CR33]\]. Furthermore, Rimachi et al. \[[@CR34]\] found the presence of hyperlactatemia in 65 % of septic shock patients, but only 76 % of these patients also had a high lactate/pyruvate ratio confirming the non-hypoxic cause of hyperlactatemia in septic states. Moreover, in fluid-responder patients, we found no significant relationship between changes in VO~2~ induced by VE and changes in lactate levels, whereas changes in ∆PCO~2~/∆ContO~2~ and ∆ContCO~2~/∆ContO~2~ ratios were correlated well with changes in VO~2~. This finding suggests that these ratios respond to changes in global tissue oxygenation faster than blood lactate concentration likely due to the alteration of lactate clearance.

The majority (71 %) of our septic shock patients had a ScvO~2~ value ≤70 % at their inclusion in the study. This finding is due to the fact that patients, in our study, were recruited in the very early period of acute circulatory failure; the time between the start of care and enrollment was only 102 min. Within this period, septic shock patients are not fully resuscitated yet, and as a consequence, low values of ScvO~2~ are observed more frequently \[[@CR35]--[@CR37]\]. Even though our population seems to be different from that in the study of Monnet et al. \[[@CR8]\], we confirm that ScvO~2~ is a poor predictor of the presence of anaerobic metabolism. This can be explained by the fact that ScvO~2~ is not a regulated parameter but an adaptive one that depends on four regulated constituents: oxygen consumption, hemoglobin, SaO~2~, and cardiac output. Therefore, ScvO~2~ is widely fluctuating. However, these results should not dissuade us from monitoring ScvO~2~ but encourage us to include it in a multimodal approach. Indeed, a low ScvO~2~ value reflects the inadequacy of oxygen supply, and fluid administration can be helpful in order to correct oxygen supply/demand imbalance, even in situations of VO~2~/DO~2~ independency, to avoid further decreases in DO~2~ below a critical value leading to tissue hypoxia. On the other hand, only ScvO~2~ values ≥80 % were able to predict the presence of global tissue hypoxia with a high specificity. All these patients also had higher lactate levels and higher ∆PCO~2~/∆ContO~2~ and ∆ContCO~2~/∆ContO~2~ ratios. This suggests that these patients had a greater alteration of their microcirculation due to sepsis than the other fluid-responder patients. However, this finding should be interpreted with caution, since only six patients had a baseline ScvO~2~ value ≥80 % in fluid-responders' group, and our study was not designed for testing this hypothesis.

Contrary to what was found previously \[[@CR8]\], DO~2~ did not decrease during VE, in fluid-non-responder patients, even though arterial hemoglobin significantly decreased by 5.6 ± 4.6 % (Additional file [2](#MOESM2){ref-type="media"}: Table S1), which was lower than that in the Monnet et al. study (8 ± 4 %) \[[@CR8]\]. The discrepancy between the two studies may be due to dissimilar populations of patients and to the differences in the time to inclusion, which was longer in the study by Monnet et al. \[[@CR8]\] than that in our study (6.1 vs. 1.7 h) explaining the more pronounced hemodilution effect in their study.

We believe our findings add significant values to the Monnet et al. study \[[@CR8]\]. Indeed, we have demonstrated that the ∆PCO~2~/∆ContO~2~ ratio is a reliable marker of global anaerobic metabolism in the very early period of septic shock where patients are still not fully resuscitated and that ∆ContCO~2~/∆ContO~2~ is not superior to ∆PCO~2~/∆ContO~2~ for predicting the presence of global tissue hypoxia in these patients. Furthermore, our study shed the light on the fact that hyperlactatemia should not always be regarded as reflecting the presence of global tissue hypoxia, especially in septic shock patients. This finding is of clinical importance since elevated lactate values could incite the clinician to undertake unnecessary interventions, with their potentially harmful effects, such as tissue edema and positive fluid balance, which have constantly been associated with poorer outcome \[[@CR38]\].

Our study presents several limitations. First, we used central venous blood instead of mixed venous to assess VO~2~- and CO~2~-derived variables, and thus, we might have missed the evaluation of the splanchnic oxygenation. However, our study is the second one that confirms that calculating oxygen-derived variables from the central venous blood is able to detect the presence of tissue hypoxia through VO~2~/DO~2~ dependence. Second, regional or local tissue hypoxia might not be detected by the assessment of the changes in global oxygen consumption. Finally, it is a single-center study, which may limit its external validity.

Conclusion {#Sec15}
==========

∆ContCO~2~/∆ContO~2~ and ∆PCO~2~/∆ContO~2~ are excellent and better markers of global anaerobic metabolism than lactate in fluid-responder septic shock patients. Also, these parameters respond to changes in global oxygenation faster than lactate. ScvO~2~ cannot predict the presence of global tissue hypoxia, except for values ≥80 %.
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CI

:   cardiac index

DO~2~

:   oxygen delivery

VO~2~

:   oxygen consumption

ScvO~2~

:   central venous oxygen saturation

∆PCO~2~

:   central venous-to-arterial carbon dioxide tension difference

∆ContCO~2~

:   central venous-to-arterial carbon dioxide content difference

∆ContO~2~

:   arterial-to-central venous oxygen content difference

CaO~2~

:   arterial oxygen content

CcvO~2~

:   central venous oxygen content

OE

:   oxygen extraction

RQ

:   respiratory quotient

VE

:   volume expansion

AUC

:   area under receiver operating characteristic curve

95 % CI

:   95 % confidence interval
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